Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA WOCKHARDT GSK PHARMA/
WOCKHARDT
 
P/E (TTM) x 62.2 -16.8 - View Chart
P/BV x 18.9 2.7 704.2% View Chart
Dividend Yield % 1.6 0.0 -  

Financials

 GSK PHARMA   WOCKHARDT
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
WOCKHARDT
Mar-23
GSK PHARMA/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs1,684316 533.7%   
Low Rs1,231145 846.7%   
Sales per share (Unadj.) Rs191.9184.0 104.3%  
Earnings per share (Unadj.) Rs35.9-43.1 -83.2%  
Cash flow per share (Unadj.) Rs39.8-25.7 -154.8%  
Dividends per share (Unadj.) Rs32.000-  
Avg Dividend yield %2.20-  
Book value per share (Unadj.) Rs102.9231.7 44.4%  
Shares outstanding (eoy) m169.41144.09 117.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.61.3 606.2%   
Avg P/E ratio x40.6-5.3 -759.9%  
P/CF ratio (eoy) x36.7-9.0 -408.5%  
Price / Book Value ratio x14.21.0 1,423.9%  
Dividend payout %89.20-   
Avg Mkt Cap Rs m246,85833,202 743.5%   
No. of employees `000NANA-   
Total wages/salary Rs m5,9506,370 93.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,51726,510 122.7%  
Other income Rs m1,0071,220 82.5%   
Total revenues Rs m33,52427,730 120.9%   
Gross profit Rs m8,033-1,930 -416.2%  
Depreciation Rs m6582,510 26.2%   
Interest Rs m183,020 0.6%   
Profit before tax Rs m8,364-6,240 -134.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,288-30 -7,625.3%   
Profit after tax Rs m6,076-6,210 -97.8%  
Gross profit margin %24.7-7.3 -339.3%  
Effective tax rate %27.40.5 5,688.9%   
Net profit margin %18.7-23.4 -79.8%  
BALANCE SHEET DATA
Current assets Rs m24,94319,140 130.3%   
Current liabilities Rs m13,26434,350 38.6%   
Net working cap to sales %35.9-57.4 -62.6%  
Current ratio x1.90.6 337.5%  
Inventory Days Days9739 247.1%  
Debtors Days Days21611 1,967.8%  
Net fixed assets Rs m6,98848,670 14.4%   
Share capital Rs m1,694720 235.3%   
"Free" reserves Rs m15,73532,660 48.2%   
Net worth Rs m17,43033,380 52.2%   
Long term debt Rs m02,240 0.0%   
Total assets Rs m31,93070,750 45.1%  
Interest coverage x462.6-1.1 -43,385.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.00.4 271.8%   
Return on assets %19.1-4.5 -423.3%  
Return on equity %34.9-18.6 -187.4%  
Return on capital %48.1-9.0 -532.0%  
Exports to sales %00-   
Imports to sales %48.13.5 1,385.1%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,630920 1,698.9%   
Fx inflow Rs m1,622730 222.1%   
Fx outflow Rs m15,630920 1,698.9%   
Net fx Rs m-14,008-190 7,372.8%   
CASH FLOW
From Operations Rs m4,8421,530 316.5%  
From Investments Rs m8,079-1,250 -646.3%  
From Financial Activity Rs m-15,433-3,150 489.9%  
Net Cashflow Rs m-2,512-2,800 89.7%  

Share Holding

Indian Promoters % 0.0 54.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 11.6 4.5 258.5%  
FIIs % 2.9 4.2 70.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 45.1 55.5%  
Shareholders   114,663 161,813 70.9%  
Pledged promoter(s) holding % 0.0 74.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs Wockhardt Share Price Performance

Period GSK Pharma Wockhardt S&P BSE HEALTHCARE
1-Day 3.26% 4.99% 1.18%
1-Month -9.77% 0.15% -0.75%
1-Year 52.63% 290.07% 61.82%
3-Year CAGR 10.89% 13.79% 18.16%
5-Year CAGR 8.44% 7.92% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of Wockhardt the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.